Non-viral gene delivery methods are changing the paradigm of genetic medicine by offering safer, more flexible, and scalable alternatives to viral-based systems. Our scientific sessions cover the novel delivery platforms, including lipid nanoparticles, polymer-based vectors, and large-scale production, which allow for precise and efficient delivery of genetic material.
At our USA Cell & Gene Therapy World Conference, leading investigators in the field of molecular biology, bioengineering, and translational medicine will present the latest advancements in non-viral delivery technologies. The conversations will be focused on vector optimization, large-scale manufacturing, regulatory challenges, and clinical translation, all while ensuring safety and therapeutic efficacy.